[144] ORACLE CORP SEC Filing
Form 144 for ORCL shows a proposed sale of 33,845 common shares through Fidelity Brokerage on the NYSE with an aggregate market value of $10,869,660.20. The filing lists two recent restricted stock vesting events that produced 11,095 and 22,750 shares, acquired as compensation. It also discloses two sales by the same person, Michael Sicilia, totaling 32,203 shares in the past three months with gross proceeds of $9,160,035.20. The filing includes the total shares outstanding of 2,841,714,000. The filer affirms there is no undisclosed material adverse information and that sales are being reported under Rule 144.
Modulo 144 per ORCL mostra una vendita proposta di 33.845 azioni ordinarie tramite Fidelity Brokerage sul NYSE, con un valore di mercato aggregato di $10.869.660,20. Il fascicolo riporta due recenti eventi di vesting di azioni soggette a restrizioni che hanno prodotto 11.095 e 22.750 azioni, acquisite come compenso. Riporta inoltre due vendite effettuate dalla stessa persona, Michael Sicilia, per un totale di 32.203 azioni negli ultimi tre mesi, con proventi lordi di $9.160.035,20. Il fascicolo indica il totale delle azioni in circolazione di 2.841.714.000. Il dichiarante attesta che non esistono informazioni materiali avverse non divulgate e che le vendite sono riportate ai sensi della Regola 144.
Formulario 144 para ORCL muestra una venta propuesta de 33.845 acciones ordinarias a través de Fidelity Brokerage en la NYSE, con un valor de mercado agregado de $10.869.660,20. El informe enumera dos recientes eventos de vesting de acciones restringidas que produjeron 11.095 y 22.750 acciones, obtenidas como compensación. También divulga dos ventas por la misma persona, Michael Sicilia, por un total de 32.203 acciones en los últimos tres meses, con ingresos brutos de $9.160.035,20. El informe incluye el total de acciones en circulación de 2.841.714.000. El presentante afirma que no hay información material adversa no divulgada y que las ventas se reportan bajo la Regla 144.
ORCL용 Form 144은 NYSE에서 Fidelity Brokerage를 통해 33,845주 일반주를 매매하는 제안이 표시되며 총 시가가 $10,869,660.20입니다. 이 서류에는 보상으로 취득된 11,095주와 22,750주의 제한된 주식 가속 vesting 이벤트가 두 건 보고됩니다. 또한 같은 사람인 Michael Sicilia가 지난 3개월 동안 32,203주를 매도했고 매출총액은 $9,160,035.20입니다. 발신인은 주식 총수인 2,841,714,000주를 포함하고 있음을 기재합니다. 제출자는 공개되지 않은 중요한 악재 정보가 없으며 매매가 규칙 144에 따라 보고되고 있음을 확인합니다.
Formulaire 144 pour ORCL montre une vente proposée de 33 845 actions ordinaires via Fidelity Brokerage sur le NYSE, d'une valeur marché totale de $10.869.660,20. Le dossier répertorie deux événements récents de vesting d'options d'actions restreintes ayant donné lieu à 11 095 et 22 750 actions, acquises en tant que rémunération. Il révèle également deux ventes par la même personne, Michael Sicilia, pour un total de 32 203 actions au cours des trois derniers mois, avec des produits bruts de $9.160.035,20. Le dossier indique le total des actions en circulation de 2 841 714 000. Le déposant affirme qu'il n'y a pas d'informations matériellement défavorables non divulguées et que les ventes sont déclarées conformément à la règle 144.
Formular 144 für ORCL zeigt einen vorgeschlagenen Verkauf von 33.845 Stammaktien über Fidelity Brokerage an der NYSE mit einem Gesamtmarktwert von $10.869.660,20. Die Einreichung listet zwei jüngste vesting-Ereignisse von Restricted Stock auf, die 11.095 bzw. 22.750 Aktien erzeugten und als Vergütung erhalten wurden. Sie gibt auch zwei Verkäufe derselben Person, Michael Sicilia, im Gesamtumfang von 32.203 Aktien in den letzten drei Monaten mit Bruttoerlösen von $9.160.035,20 an. Die Einreichung enthält die gesamte ausstehende Anzahl von 2.841.714.000 Aktien. Der Einreicher bestätigt, dass keine unbekannten wesentlichen nachteiligen Informationen vorliegen und dass die Verkäufe gemäß Regel 144 gemeldet werden.
نموذج 144 لـ ORCL يظهر بيعًا مقترحًا لـ 33,845 سهماً عاديًا عبر Fidelity Brokerage في بورصة نيويورك، بقيمة سوقية إجمالية قدرها $10,869,660.20. يسرد الملف حدثين حديثين لتقييد الأسهم vesting الذي أنتج 11,095 و22,750 سهماً، اكتسبت كتعويض. كما يكشف عن عمليتي بيع من نفس الشخص، مايكل سيسليا، بإجمالي 32,203 سهماً في الأشهر الثلاثة الأخيرة مع عائدات إجمالية قدرها $9,160,035.20. الملف يشمل إجمالي الأسهم القائمة البالغ 2,841,714,000 سهماً. يؤكد الملتمس أنه لا توجد معلومات سلبية مادية غير مكتشفة وأن البيعات يتم الإبلاغ عنها وفق Rule 144.
Form 144 适用于 ORCL 显示通过 Fidelity Brokerage 在 NYSE 提议出售 33,845 股普通股，市值总额为 $10,869,660.20。文件列出两起最近的受限股票归属事件，分别产生 11,095 股和 22,750 股，作为报酬取得。还披露同一人 Michael Sicilia 在过去三个月内两次出售，总计 32,203 股，毛收入为 $9,160,035.20。文件还包含发行在外的总股数 2,841,714,000 股。披露人声明不存在未披露的重大不利信息，且销售按规则 144 报告。
- Transparent Rule 144 reporting of proposed sale and recent transactions providing investor visibility
- Shares originated from restricted stock vesting, indicating the securities were issued as compensation rather than acquired in open-market purchases
- Insider sales totaling meaningful proceeds (~$9.16M in past three months and a proposed $10.87M sale) which could be perceived negatively by some investors
Insights
TL;DR: Insider sales reported are meaningful in dollar terms but small relative to the company’s outstanding shares, indicating limited market impact.
These entries show a proposed 33,845-share sale valued at about $10.9 million funded by recently vested restricted stock. Recent dispositions by the same individual generated roughly $9.16 million across two trades. As a percentage of the reported 2.84 billion shares outstanding, these volumes are immaterial, suggesting the transactions are unlikely to move the market. The activity is, however, relevant for transparency and insider liquidity analysis.
TL;DR: Filing documents standard Rule 144 reporting and shows insider monetization of compensation via vesting and sales.
The filing documents restricted stock vesting followed by proposed sale under Rule 144 and recent completed sales by the same individual. That pattern is consistent with executives or insiders converting compensation into cash. The signer’s attestation that no undisclosed material adverse information exists is standard. Investors monitoring insider behavior will note continuity of sales, but the filing contains no disclosure of any governance or control changes.
Modulo 144 per ORCL mostra una vendita proposta di 33.845 azioni ordinarie tramite Fidelity Brokerage sul NYSE, con un valore di mercato aggregato di $10.869.660,20. Il fascicolo riporta due recenti eventi di vesting di azioni soggette a restrizioni che hanno prodotto 11.095 e 22.750 azioni, acquisite come compenso. Riporta inoltre due vendite effettuate dalla stessa persona, Michael Sicilia, per un totale di 32.203 azioni negli ultimi tre mesi, con proventi lordi di $9.160.035,20. Il fascicolo indica il totale delle azioni in circolazione di 2.841.714.000. Il dichiarante attesta che non esistono informazioni materiali avverse non divulgate e che le vendite sono riportate ai sensi della Regola 144.
Formulario 144 para ORCL muestra una venta propuesta de 33.845 acciones ordinarias a través de Fidelity Brokerage en la NYSE, con un valor de mercado agregado de $10.869.660,20. El informe enumera dos recientes eventos de vesting de acciones restringidas que produjeron 11.095 y 22.750 acciones, obtenidas como compensación. También divulga dos ventas por la misma persona, Michael Sicilia, por un total de 32.203 acciones en los últimos tres meses, con ingresos brutos de $9.160.035,20. El informe incluye el total de acciones en circulación de 2.841.714.000. El presentante afirma que no hay información material adversa no divulgada y que las ventas se reportan bajo la Regla 144.
ORCL용 Form 144은 NYSE에서 Fidelity Brokerage를 통해 33,845주 일반주를 매매하는 제안이 표시되며 총 시가가 $10,869,660.20입니다. 이 서류에는 보상으로 취득된 11,095주와 22,750주의 제한된 주식 가속 vesting 이벤트가 두 건 보고됩니다. 또한 같은 사람인 Michael Sicilia가 지난 3개월 동안 32,203주를 매도했고 매출총액은 $9,160,035.20입니다. 발신인은 주식 총수인 2,841,714,000주를 포함하고 있음을 기재합니다. 제출자는 공개되지 않은 중요한 악재 정보가 없으며 매매가 규칙 144에 따라 보고되고 있음을 확인합니다.
Formulaire 144 pour ORCL montre une vente proposée de 33 845 actions ordinaires via Fidelity Brokerage sur le NYSE, d'une valeur marché totale de $10.869.660,20. Le dossier répertorie deux événements récents de vesting d'options d'actions restreintes ayant donné lieu à 11 095 et 22 750 actions, acquises en tant que rémunération. Il révèle également deux ventes par la même personne, Michael Sicilia, pour un total de 32 203 actions au cours des trois derniers mois, avec des produits bruts de $9.160.035,20. Le dossier indique le total des actions en circulation de 2 841 714 000. Le déposant affirme qu'il n'y a pas d'informations matériellement défavorables non divulguées et que les ventes sont déclarées conformément à la règle 144.
Formular 144 für ORCL zeigt einen vorgeschlagenen Verkauf von 33.845 Stammaktien über Fidelity Brokerage an der NYSE mit einem Gesamtmarktwert von $10.869.660,20. Die Einreichung listet zwei jüngste vesting-Ereignisse von Restricted Stock auf, die 11.095 bzw. 22.750 Aktien erzeugten und als Vergütung erhalten wurden. Sie gibt auch zwei Verkäufe derselben Person, Michael Sicilia, im Gesamtumfang von 32.203 Aktien in den letzten drei Monaten mit Bruttoerlösen von $9.160.035,20 an. Die Einreichung enthält die gesamte ausstehende Anzahl von 2.841.714.000 Aktien. Der Einreicher bestätigt, dass keine unbekannten wesentlichen nachteiligen Informationen vorliegen und dass die Verkäufe gemäß Regel 144 gemeldet werden.
FAQ
What does the Form 144 for ORCL report?
How many shares were acquired through vesting listed in the filing?
What insider sales occurred in the past three months according to the filing?
How large are these transactions relative to shares outstanding?
Does the filer assert there is undisclosed material information?
